Baxter International Inc.BAXNYSE
Loading
R&D Expense Growth AcceleratingAccelerating
Percentile Rank67
3Y CAGR+36.8%
5Y CAGR-7.0%
Year-over-Year Change
Year-over-year research & development expense growth
3Y CAGR
+36.8%/yr
Quarterly compound
5Y CAGR
-7.0%/yr
Recent acceleration
Percentile
P67
Within normal range
vs 5Y Ago
0.7x
Contraction
Streak
1 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q4 2025 | 6.78% |
| Q3 2025 | -11.94% |
| Q2 2025 | -4.29% |
| Q1 2025 | -33.65% |
| Q4 2024 | 63.57% |
| Q3 2024 | -0.77% |
| Q2 2024 | 8.33% |
| Q1 2024 | -30.23% |
| Q4 2023 | 29.32% |
| Q3 2023 | -19.39% |
| Q2 2023 | 0.61% |
| Q1 2023 | 5.81% |
| Q4 2022 | 2.65% |
| Q3 2022 | 2.03% |
| Q2 2022 | -1.33% |
| Q1 2022 | 8.70% |
| Q4 2021 | 6.98% |
| Q3 2021 | -7.19% |
| Q2 2021 | 8.59% |
| Q1 2021 | -5.19% |
| Q4 2020 | 9.76% |
| Q3 2020 | 5.13% |
| Q2 2020 | -19.86% |
| Q1 2020 | -6.41% |
| Q4 2019 | 8.33% |
| Q3 2019 | -13.25% |
| Q2 2019 | 28.68% |
| Q1 2019 | -26.29% |
| Q4 2018 | 5.42% |
| Q3 2018 | -4.60% |
| Q2 2018 | 24.29% |
| Q1 2018 | -23.08% |
| Q4 2017 | 21.33% |
| Q3 2017 | -3.23% |
| Q2 2017 | 22.05% |
| Q1 2017 | -19.11% |
| Q4 2016 | -1.26% |
| Q3 2016 | -18.46% |
| Q2 2016 | 43.38% |
| Q1 2016 | -15.53% |